Karen A. Tourian

A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder

Daniel Z. Lieberman, Stuart Montgomery, Karen A. Tourian et al. · International Clinical Psychopharmacology · 2008 · 216 citations

Psychotropic Medication, Pharmacotherapy, Mental Health +16

A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder

John S. March, A. Richard Entusah, Moira A. Rynn et al. · Biological Psychiatry · 2007 · 160 citations

Psychiatry, Pediatrics, Depression +7

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

Michael R. Liebowitz, Amy Manley, Sudharshan K. Padmanabhan et al. · Current Medical Research and Opinion · 2008 · 134 citations

Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial

P Boyer, Stuart Montgomery, Ulla Lepola et al. · International Clinical Psychopharmacology · 2008 · 123 citations

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder

L. Septien-Velez, B. Pitrosky, Sudharshan K. Padmanabhan et al. · International Clinical Psychopharmacology · 2007 · 95 citations